The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Novel Therapies Based on Mechanisms of HIV-1 Cell Entry
Abstract
Inhibitors of human immunodeficiency virus type 1 (HIV-1) enzymes are central to the treatment of HIV-1 infection, but the development of resistant viruses remains a problem. Another approach is to thwart the entry of the virus into cells by preventing the fusion of the viral envelope with the cell surface. This article reviews the way in which HIV-1 enters cells and potential means of denying the virus admission to cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Contribution of Human α-Defensin 1, 2, and 3 to the Anti-HIV-1 Activity of CD8 Antiviral Factor
Zhang, L., Yu, W., He, T., Yu, J., Caffrey, R. E., Dalmasso, E. A., Fu, S., Pham, T., Mei, J., Ho, J. J., et al. (2002) · Science · doi:10.1126/science.1076185 · Cited by 468
RetractedBarré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,174
Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,869
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,484
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.-C., & Montagnier, L. (1984) · Nature · doi:10.1038/312767a0 · Cited by 2,436
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81313-6 · Cited by 2,287
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
Wyatt, R., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1884 · Cited by 1,598
Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1896-1905.2002 · Cited by 1,569
Self-citationIsolation of Human T-Cell Leukemia Virus in Acquired Immune Deficiency Syndrome (AIDS)
Gallo, R. C., Sarin, P. S., Gelmann, E. P., Robert-Guroff, M., Richardson, E., Kalyanaraman, V. S., Mann, D., Sidhu, G. D., Stahl, R. E., Zolla-Pazner, S., et al. (1983) · Science · doi:10.1126/science.6601823 · Cited by 1,238
Kilby, J. M., Hopkins, S., Venetta, T. M., DiMassimo, B., Cloud, G. A., Lee, J. Y., Alldredge, L., Hunter, E., Lambert, D., Bolognesi, D., et al. (1998) · Nature Medicine · doi:10.1038/3293 · Cited by 987
Self-citationEnfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America
Lalezari, J. P., Henry, K., O'Hearn, M., Montaner, J. S. G., Piliero, P. J., Trottier, B., Walmsley, S., Cohen, C., Kuritzkes, D. R., Eron, J. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035026 · Cited by 914
Self-citationA spring-loaded mechanism for the conformational change of influenza hemagglutinin
Carr, C. M., & Kim, P. S. (1993) · Cell · doi:10.1016/0092-8674(93)90260-w · Cited by 857
Functional Regions of the Envelope Glycoprotein of Human Immunodeficiency Virus Type 1
Kowalski, M., Potz, J., Basiripour, L., Dorfman, T., Goh, W. C., Terwilliger, E., Dayton, A., Rosen, C., Haseltine, W., & Sodroski, J. (1987) · Science · doi:10.1126/science.3629244 · Cited by 848
Lasky, L. A., Nakamura, G., Smith, D. H., Fennie, C., Shimasaki, C., Patzer, E., Berman, P., Gregory, T., & Capon, D. J. (1987) · Cell · doi:10.1016/0092-8674(87)90524-1 · Cited by 828
Koot, M., Keet, I. P. M., Vos, A. H. V., de Goede, R. E. Y., Roos, M. T. L., Coutinho, R. A., Miedema, F., Schellekens, P. T. A., & Tersmette, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-9-199305010-00004 · Cited by 785
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
Donzella, G. A., Schols, D., Lin, S. W., Esté, J. A., Nagashima, K. A., Maddon, P. J., Allaway, G. P., Sakmar, T. P., Henson, G., DeClercq, E., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-072 · Cited by 760
Derdeyn, C. A., Decker, J. M., Sfakianos, J. N., Wu, X., O'Brien, W. A., Ratner, L., Kappes, J. C., Shaw, G. M., & Hunter, E. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8358-8367.2000 · Cited by 742
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
Lazzarin, A., Clotet, B., Cooper, D., Reynes, J., Arastéh, K., Nelson, M., Katlama, C., Stellbrink, H.-J., Delfraissy, J.-F., Lange, J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035211 · Cited by 656
Potent Inhibition of HIV-1 Infectivity in Macrophages and Lymphocytes by a Novel CCR5 Antagonist
Simmons, G., Clapham, P. R., Picard, L., Offord, R. E., Rosenkilde, M. M., Schwartz, T. W., Buser, R., Wells, T. N. C., & Proudfoot, A. E. I. (1997) · Science · doi:10.1126/science.276.5310.276 · Cited by 608
Hendrix, C. W., Flexner, C., MacFarland, R. T., Giandomenico, C., Fuchs, E. J., Redpath, E., Bridger, G., & Henson, G. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1667-1673.2000 · Cited by 504
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Cara, A., Gallo, R. C., & Lusso, P. (1996) · Nature Medicine · doi:10.1038/nm1196-1244 · Cited by 495
Trkola, A., Pomales, A. B., Yuan, H., Korber, B., Maddon, P. J., Allaway, G. P., Katinger, H., Barbas, C. F., Burton, D. R., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6609-6617.1995 · Cited by 480
Mitsuya, H., Looney, D. J., Kuno, S., Ueno, R., Wong-Staal, F., & Broder, S. (1988) · Science · doi:10.1126/science.2452480 · Cited by 463
HIV infection is blocked in vitro by recombinant soluble CD4
Fisher, R. A., Bertonis, J. M., Meier, W., Johnson, V. A., Costopoulos, D. S., Liu, T., Tizard, R., Walker, B. D., Hirsch, M. S., Schooley, R. T., et al. (1988) · Nature · doi:10.1038/331076a0 · Cited by 446
Eckert, D. M., Malashkevich, V. N., Hong, L. H., Carr, P. A., & Kim, P. S. (1999) · Cell · doi:10.1016/s0092-8674(00)80066-5 · Cited by 442
A soluble CD4 protein selectively inhibits HIV replication and syncytium formation
Hussey, R. E., Richardson, N. E., Kowalski, M., Brown, N. R., Chang, H.-C., Siliciano, R. F., Dorfman, T., Walker, B., Sodroski, J., & Reinherz, E. L. (1988) · Nature · doi:10.1038/331078a0 · Cited by 427
Dragic, T., Trkola, A., Thompson, D. A. D., Cormier, E. G., Kajumo, F. A., Maxwell, E., Lin, S. W., Ying, W., Smith, S. O., Sakmar, T. P., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090576697 · Cited by 426
Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides
Rimsky, L. T., Shugars, D. C., & Matthews, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.986-993.1998 · Cited by 423
Reeves, J. D., Gallo, S. A., Ahmad, N., Miamidian, J. L., Harvey, P. E., Sharron, M., Pöhlmann, S., Sfakianos, J. N., Derdeyn, C. A., Blumenthal, R., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252469399 · Cited by 404
Richman, D. D., & Bozzette, S. A. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.5.968 · Cited by 401
A Synthetic Peptide from HIV-1 gp41 Is a Potent Inhibitor of Virus-Mediated Cell—Cell Fusion
Wild, C., Greenwell, T., & Matthews, T. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.1051 · Cited by 398
A General Model for the Transmembrane Proteins of HIV and Other Retroviruses
GALLAHER, W. R., BALL, J. M., GARRY, R. F., GRIFFIN, M. C., & MONTELARO, R. C. (1989) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1989.5.431 · Cited by 368
Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
Earl, P. L., Doms, R. W., & Moss, B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.648 · Cited by 359
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use
Trkola, A., Kuhmann, S. E., Strizki, J. M., Maxwell, E., Ketas, T., Morgan, T., Pugach, P., Xu, S., Wojcik, L., Tagat, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012519099 · Cited by 303
Strizki, J. M., Xu, S., Wagner, N. E., Wojcik, L., Liu, J., Hou, Y., Endres, M., Palani, A., Shapiro, S., Clader, J. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221375398 · Cited by 299
Moulard, M., Lortat-Jacob, H., Mondor, I., Roca, G., Wyatt, R., Sodroski, J., Zhao, L., Olson, W., Kwong, P. D., & Sattentau, Q. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.4.1948-1960.2000 · Cited by 297
Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4
Peterson, A., & Seed, B. (1988) · Cell · doi:10.1016/0092-8674(88)90180-8 · Cited by 293
Moore, J. P., McKeating, J. A., Huang, Y. X., Ashkenazi, A., & Ho, D. D. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.235-243.1992 · Cited by 284
Cell surface receptors, virus entry and tropism of primate lentiviruses
Clapham, P. R., & McKnight, Á. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-8-1809 · Cited by 256
Moore, J. P., Sattentau, Q. J., Wyatt, R., & Sodroski, J. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.469-484.1994 · Cited by 248
Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4
Skinner, M. A., Langlois, A. J., McDanal, C. B., McDougal, J. S., Bolognesi, D. P., & Matthews, T. J. (1988) · Journal of Virology · doi:10.1128/jvi.62.11.4195-4200.1988 · Cited by 227
Trkola, A., Ketas, T. J., Nagashima, K. A., Zhao, L., Cilliers, T., Morris, L., Moore, J. P., Maddon, P. J., & Olson, W. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.579-588.2001 · Cited by 224
Freed, E. O., Myers, D. J., & Risser, R. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.190-194.1991 · Cited by 219
Wyatt, R., Sullivan, N., Thali, M., Repke, H., Ho, D., Robinson, J., Posner, M., & Sodroski, J. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4557-4565.1993 · Cited by 214
Kilby, J. M., Lalezari, J. P., Eron, J. J., Carlson, M., Cohen, C., Arduino, R. C., Goodgame, J. C., Gallant, J. E., Volberding, P., Murphy, R. L., et al. (2002) · AIDS Research and Human Retroviruses · doi:10.1089/088922202760072294 · Cited by 198
Self-citationSchooley, R. T., Merigan, T. C., Gaut, P., Hirsch, M. S., Holodniy, M., Flynn, T., Liu, S., Byington, R. E., Henochowicz, S., Gubish, E., et al. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-4-247 · Cited by 192
Dubay, J. W., Roberts, S. J., Brody, B., & Hunter, E. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.4748-4756.1992 · Cited by 189
Derdeyn, C. A., Decker, J. M., Sfakianos, J. N., Zhang, Z., O'Brien, W. A., Ratner, L., Shaw, G. M., & Hunter, E. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8605-8614.2001 · Cited by 182
Mosier, D. E., Picchio, G. R., Gulizia, R. J., Sabbe, R., Poignard, P., Picard, L., Offord, R. E., Thompson, D. A., & Wilken, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3544-3550.1999 · Cited by 182
The University of North Carolina at Chapel Hill University Libraries (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/81xb-we92 · Cited by 180
Chen, C. H., Matthews, T. J., McDanal, C. B., Bolognesi, D. P., & Greenberg, M. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3771-3777.1995 · Cited by 169
Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles
Weiss, C. D., Levy, J. A., & White, J. M. (1990) · Journal of Virology · doi:10.1128/jvi.64.11.5674-5677.1990 · Cited by 160
Flexner, C. W., Barditch‐Crovo, P., Kornhauser, D. M., Farzadegan, H., Nerhood, L., Chaisson, R. E., Bell, K. M., Lorentsen, K. J., Hendrix, C. W., & Petty, B. G. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.12.2544 · Cited by 153
Lalezari, J. P., Eron, J. J., Carlson, M., Cohen, C. J., DeJesus, E., Arduino, R. C., Gallant, J. E., Volberding, P. A., Murphy, R. L., Valentine, F. T., et al. (2003) · AIDS · doi:10.1097/00002030-200303280-00007 · Cited by 150
Self-citationRusconi, S., Moonis, M., Merrill, D. P., Pallai, P. V., Neidhardt, E. A., Singh, S. K., Willis, K., Osburne, M. S., Profy, A. T., Jenson, J. C., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.1.234 · Cited by 145
Harrison, S. C., Ferrer, M., Kapoor, T. M., Strassmaier, T., Weissenhorn, W., Skehel, J. J., Oprian, D., Schreiber, S. L., & Wiley, D. C. (1999) · Nature Structural Biology · doi:10.1038/13324 · Cited by 139
Judice, J. K., Tom, J., Huang, W., Wrin, T., Vennari, J., Petropoulos, C. J., & McDowell, R. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13426 · Cited by 134
The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication
de Vreese, K., Kofler-Mongold, V., Leutgeb, C., Weber, V., Vermeire, K., Schacht, S., Anné, J., Clercq, E. D., DATEMA, R., & Werner, G. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.689-696.1996 · Cited by 130
Retroviral Envelope Glycoproteins Contain a "Leucine Zipper"-like Repeat
Delwart, E., Mosialos, G., & Gilmore, T. D. (1990) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1990.6.703 · Cited by 124
Safe Use of the CXCR4 Inhibitor ALX40-4C in Humans
Doranz, B. J., Filion, L. G., Díaz‐Mitoma, F., SITAR, D. S., Sahai, J. V., Baribaud, F., Orsini, M. J., Benovic, J., Cameron, D. W., & Doms, R. W. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220151126508 · Cited by 118
Chemokines and HIV-1 second receptors: The therapeutic connection
Cairns, J. S., & D’Souza, M. P. (1998) · Nature Medicine · doi:10.1038/nm0598-563 · Cited by 114
Damme, L. V., Wright, A., Depraetere, K., Rosenstein, I., Vandersmissen, V., Poulter, L., McKinlay, M., Dyck, E. V., Weber, J., Profy, A., et al. (2000) · Sexually Transmitted Infections · doi:10.1136/sti.76.2.126 · Cited by 108
Nagashima, K. A., Thompson, D. A. D., Rosenfield, S. I., Maddon, P. J., Dragic, T., & Olson, W. C. (2001) · The Journal of Infectious Diseases · doi:10.1086/319284 · Cited by 105
Mori, T., & Boyd, M. R. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.664-672.2001 · Cited by 103
Tremblay, C. L., Giguel, F. F., Kollmann, C. S., Guan, Y., Chou, T., Baroudy, B. M., & Hirsch, M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1336-1339.2002 · Cited by 86
Recombinant CD4‐IgG2 in Human Immunodeficiency Virus Type 1–Infected Children: Phase 1/2 Study
Shearer, W. T., Israel, R. J., Starr, S. E., Fletcher, C. V., Wara, D. W., Rathore, M. H., Church, J. A., Deville, J. G., Fenton, T., Graham, B., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/317622 · Cited by 78
Mapping genetic determinants for human immunodeficiency virus type 1 resistance to soluble CD4
O’Brien, W. A., Chen, I. S., Ho, D. D., & Daar, E. S. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.3125-3130.1992 · Cited by 57
CD4-independent utilization of the CXCR4 chemokine receptor by HIV-1 and HIV-2
Hoxie, J. A., LaBranche, C. C., Endres, M. J., Turner, J. D., Berson, J. F., Doms, R. W., & Matthews, T. J. (1998) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(98)00059-x · Cited by 55
Singh, A., & Collman, R. G. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10229-10235.2000 · Cited by 53
Rusconi, S., Catamancio, S. L. S., Citterio, P., Bulgheroni, E., Croce, F., Herrmann, S. H., Offord, R. E., Galli, M., & Hirsch, M. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9328-9332.2000 · Cited by 27
Meng, T., Fischl, M. A., Cheeseman, S. H., Spector, S. A., Resnick, L., Boota, A. M., Petrakis, T., Wright, B. C., & Richman, D. D. (1995) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199502000-00006 · Cited by 17
Regeneration of T Cells after Chemotherapy
Moreland, L. W., Bucy, R. P., & Koopman, W. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322414 · Cited by 14
Cited by
Harrison, S. C. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1456 · Cited by 1,190
Clavel, F., & Hance, A. J. (2004) · New England Journal of Medicine · doi:10.1056/nejm2ra025195 · Cited by 800
Virus entry: molecular mechanisms and biomedical applications
Dimitrov, D. S. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro817 · Cited by 701
Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes
Matthews, T., Salgo, M., Greenberg, M., Chung, J., DeMasi, R., & Bolognesi, D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1331 · Cited by 465
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
Lu, L., Liu, Q., Zhu, Y., Chan, K.-H., Qin, L., Li, Y., Wang, Q., Chan, J. F.-W., Du, L., Yu, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms4067 · Cited by 388
Metadata
- Authors
- Kilby, J. M., & Eron, J. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-05-29
- Volume
- 348
- Issue
- 22
- Pages
- 2228-2238
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2032020323
- Cited by
- 254
- References
- 78
- FWCI
- 9.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.